Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocrystalline Megestrol Acetate in Cancer Cachexia
NCT07243379Phase 4Recruiting
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of megestrol in cancer cachexia, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd. Primary endpoint: Proportion of patients with improved appetite based on the A/CS-12 scale at 4 weeks. Started Sep 2025; status: recruiting.
02
Drugs
megestrol
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT07243379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07243379.